LETTER
Chiral Source for the Enantioselective Synthesis of Heterocycles
1689
(6) Stájer, G.; Csende, F.; Fülöp, F. Curr. Org. Chem. 2003, 7,
1423.
137.85, 169.96, 172.35. MS: m/z = 233 [M + H]+.
Compound (+)-2b: colorless crystals, mp 134–136 °C
(7) (a) Stájer, G.; Szabó, A. E.; Fülöp, F.; Bernáth, G. Synthesis
1984, 345. (b) Miklós, F.; Stájer, G.; Sohár, P.; Böcskei, Z.
Synlett 2000, 67. (c) Stájer, G.; Miklós, F.; Sohár, P.;
Sillanpää, R. Eur. J. Org. Chem. 2001, 4153. (d) Stájer, G.;
Szabó, A. E.; Sohár, P.; Csámpai, A.; Sillanpää, R. J. Mol.
Struct. 2006, 784, 239. (e) Stájer, G.; Miklós, F.; Kanizsai,
I.; Csende, F.; Sillanpää, R.; Sohár, P. Eur. J. Org. Chem.
2004, 3701.
(8) (a) Fülöp, F.; Huber, I.; Szabó, ; Bernáth, G.; Sohár, P.
Tetrahedron 1991, 47, 7673. (b) Fülöp, F.; Palkó, M.;
Bernáth, G.; Sohár, P. Synth. Commun. 1997, 27, 195.
(9) (a) Handbook of Chiral Chemicals, 2nd ed.; Ager, D., Ed.;
CRC Press/Taylor and Francis: Boca Raton, 2006.
(b) Asymmetric Synthesis – The Essentials; Christmann, M.;
Bräse, S., Eds.; Wiley-VCH: Weinheim, 2007.
(Et2O–n-hexane); [a]D25 +37 (c 0.25, MeOH). IR (KBr):
3178, 1705, 1661, 817 cm–1. 1H NMR (400 MHz, DMSO):
d = 9.48 (br s, NH), 7.23–7.07 (m, 4 ArH), 6.15 (dd, J = 2.9,
5.8 Hz, H-7), 6.11 (dd, J = 3.0, 5.6 Hz, H-8), 4.21 (br s, H-
9), 3.25 (br s, H-6), 3.13 (d, J = 7.9 Hz, H-9a), 2.54–2.35 (m,
2 H, H-2), 2.33–2.22 (m, H-3), 2.27 (s, 3 H, CH3-Ar), 2.04
(m, H-3), 1.62 (d, J = 7.7 Hz, H-5a), 1.33 (d, J = 8.8 Hz, H-
10), 1.27 (d, J = 8.8 Hz, H-10). 13C NMR (100 MHz,
DMSO): d = 20.43, 29.30, 34.67, 42.24, 42.63, 43.81, 44.86,
54,08, 77.14, 124.75 (2 × C), 129.56 (2 × C), 135.95, 137.23,
137.66, 140.45, 170.57, 173.36. MS: m/z = 309 [M + H]+.
Compound (+)-3b: colorless powder, mp 247–248 °C
(EtOAc); [a]D25 +40 (c 0.28, MeOH). IR (KBr): 3161, 1704,
1648, 815 cm–1. 1H NMR (400 MHz, DMSO): d = 9.58 (br
s, NH), 7.28–7.17 (m, 4 ArH), 6.26 (dd, J = 3.2, 5.4 Hz, H-
7), 6.20 (dd, J = 2.8, 5.6 Hz, H-8), 4.12 (d, J = 8.8 Hz, H-9a),
2.92 (br s, H-6), 2.62 (br s, H-9), 2.50–2.23 (m, 2 H, H-2),
2.30 (m, H-3a), 2.28 (s, 3 H, CH3-Ar), 2.20 (d, J = 8.8 Hz,
H-3), 2.00 (m, H-3), 0.78 (d, J = 9.1 Hz, H-10), 0.60 (d,
J = 9.1 Hz, H-10). 13C NMR (100 MHz, DMSO): d = 20.44,
28.05, 39.28, 39.70, 44.27, 46.45, 46.58, 50.95, 76.36,
123.76 (2 × C), 129.14 (2 × C), 136.73, 137.53, 137.79,
142.60, 168.98, 173.73. MS: m/z = 309 [M + H]+.
(10) (a) Anaya de Parrodi, C.; Juaristi, E. Synlett 2006, 2699.
(b) Gnas, Y.; Glorius, F. Synthesis 2006, 1899.
(11) Stájer, G.; Mód, L.; Szabó, A. E.; Fülöp, F.; Bernáth, G.;
Sohár, P. Tetrahedron 1984, 40, 2385.
(12) (a) Sohár, P.; Csámpai, A.; Szabó, A. E.; Stájer, G. J. Mol.
Struct. 2004, 694, 139. (b) Stájer, G.; Szabó, A. E.; Fülöp,
F.; Bernáth, G.; Sohár, P. Chem. Ber. 1987, 120, 259.
(13) (a) Forró, E.; Fülöp, F. Org. Lett. 2003, 5, 1209. (b) Forró,
E.; Fülöp, F. Tetrahedron: Asymmetry 2004, 15, 573.
(14) Miklós, F.; Stájer, G.; Fülöp, F. Lett. Org. Chem. 2006, 3,
915.
(22) Syntheses of Pyrrolo[1,2-a]pyrimidines by Microwave-
Induced Retro-Diels–Alder Reaction
All microwave-induced reactions were performed in sealed
reaction vials. Tetracycle 2a, 2b, or 3b (200 mg) was placed
in a microwave test tube (10 mL) subsequently sealed with a
Teflon cap, which contained a magnetic stirrer and o-DCB
(2 mL). The test tube was placed in the microwave (CEM,
Discover) cavity. The solutions were irradiated at 250 °C
(power 250 W) for 10 min then cooled to r.t., CHCl3 (6 mL)
was added, and the solution was transferred to a SiO2 column
and eluted with EtOAc.
Compound (–)-4a: synthesized from (+)-2a, colorless
crystals, mp 170–172 °C (i-Pr2O–EtOAc); [a]D25 –445 (c
0.23, MeOH), ee >99%. IR (KBr): 3182, 1734, 1667, 826
cm–1. 1H NMR (400 MHz, DMSO): d = 8.22 (br s, NH), 7.31
(d, J = 7.8 Hz, H-4), 5.25 (dd, J = 1.9, 7.8 Hz, H-3), 2.69–
2.40 (m, 2 H, H-7), 2.20–2.02 (m, 2 H, H-8), 1.41 (s, 3 H,
CH3). 13C NMR (100 MHz, DMSO): d = 24.03, 29.00, 33.37,
73.08, 105.05, 130.65, 163.03, 170.28. MS: m/z = 167 [M +
H]+.
(15) Gao, J.; Henry, R. F.; Pagano, T. G.; Duerst, R. W.; Souers,
A. J. Tetrahedron Lett. 2007, 48, 7395.
(16) (a) Mutz, M.; Fischer, R. WO 2007082946, 2007.
(b) Nakazato, A.; Okubo, T.; Nozawa, H.; Minda, T.;
Kenneth, L. E. JP 2007169216, 2007. (c) Haberg, A.; Qu,
H.; Hjelstuen, M. H.; Sonnewald, U. Neurochem. Int. 2007,
50, 932. (d) Ishikawa, T.; Miwa, K.; Seto, M.; Banno, H.;
Kawakita, Y. WO 2007064045, 2007. (e) Nagle, A.; Gray,
N. S. WO 2007053343, 2007.
(17) Tietze, L. F.; Brasche, G.; Kersten, G. Domino Reactions in
Organic Synthesis; Wiley-VCH: Weinheim, 2006.
(18) Lázár, L.; Fülöp, F. Eur. J. Org. Chem. 2003, 3025.
(19) (a) Meyers, A. I.; Downing, S. W.; Weiser, M. J. J. Org.
Chem. 2001, 66, 1413. (b) Fülöp, F.; Pihlaja, K.
Tetrahedron 1993, 49, 6701.
(20) (1S,2S,3R,4R)-3-Aminobicyclo[2.2.1]hept-5-ene-2-
carboxamide [(–)-1]
Ethyl (1S,2S,3R,4R)-3-aminobicyclo[2.2.1]hept-5-ene-2-
carboxylate (2.5 g, 13.8 mmol) was left to stand at r.t. for 3
weeks in MeOH (50 mL) saturated with NH3. The solution
was then evaporated and the solid residue was crystallized
from MeOH–Et2O, which afforded (–)-1 (72%) as colorless
needles, mp 131–133 °C; [a]D25 –4.8 (c 0.51, MeOH).
(21) Synthesis of Pyrrolo[1,2-a]quinazolines 2 and 3
diexo-3-Aminobicyclo[2.2.1]hept-5-ene-2-carboxamide
[(–)-1, (0.76 g, 5 mmol], levulinic acid or p-toluoylpropionic
acid (5.2 mmol), and PTSA (0.05 g) in toluene (25 mL) was
refluxed for 14 h. The solvent was then evaporated off, and
the residue was dissolved in CHCl3 (10 mL) and the products
were separated on a SiO2 column with a mixture of n-
hexane–EtOAc–EtOH (5:4:1).
Compound (–)-4b: synthesized from (+)-2b, colorless
crystals, mp 198–200 °C (i-Pr2O–EtOAc); [a]D25 –311 (c
0.14, MeOH), ee >99%. IR (KBr): 3184, 1728, 1667, 817
cm–1. 1H NMR (400 MHz, DMSO): d = 9.17 (br s, NH), 7.49
(d, J = 7.7 Hz, H-4), 7.22–7.16 (m, 4 ArH), 5.21 (dd, J = 7.7,
1.9 Hz, H-3), 2.59–2.36 [m, 3 H, H-7 (2 H) and H-8 (1 H)],
2.28 (s, 3 H, CH3), 2.28–2.20 (m, 1 H, H-8). 13C NMR
(100.62 MHz, DMSO): d = 20.46, 28.54, 35.47, 76.14,
106.91, 124.33 (2×), 129.08 (2×), 131,62, 137.42, 139.98,
163.23, 171.26. MS: m/z = 243 [M + H]+.
Compound (+)-4b: synthesized from (+)-3b, colorless
crystals, mp 197–199 °C (i-Pr2O×EtOAc); [a]D25 +310 (c
0.11, MeOH), ee >99%. 1H NMR and 13C NMR data were
identical to the compound (–)-4b.
Compound (+)-2a: yield 86%, colorless crystals, mp 173–
175 °C (EtOAc–i-Pr2O); [a]D25 +49 (c 0.27, MeOH). IR
(KBr): 3173, 1701, 1659, 707 cm–1. 1H NMR (400 MHz,
DMSO): d = 8.69 (br s, NH), 6.29 (dd, J = 2.7, 5.5 Hz, H-7),
6.17 (dd, J = 2.7, 5.5 Hz, H-8), 4.05 (br s, H-9), 3.34 (d,
J = 7.8 Hz, H-8a), 3.27 (br s, H-6), 2.39–2.32 (m, 2 H, H-2),
2.29 (d, J = 7.8 Hz, H-5a), 2.02 (m, H-3), 1.87 (m, H-3), 1.37
(s, 3 H, CH3-3a), 1.27 (d, J = 8.7 Hz, H-10), 1.20 (d, J = 8.7
Hz, H-10). 13C NMR (100 MHz, DMSO): d = 26.12, 29.49,
32.28, 41.69, 43.11, 43.38, 45.23, 52.32, 73.14, 135.70,
(23) The ee value for pyrrolo[1,2-a]pyrimidine (–)-4a was
determined by GC on a Chromopack Chiralsil-Dex CB
column (25 m) [120 °C for 7 min → 190 °C (temperature
rise 20 °C min–1; 100 kPa; (–)-4a: tR = 23.25 min (antipode:
24.70)]. The ee values for pyrrolo[1,2-a]pyrimidine (–)-4b
and (+)-4b were determined by HPLC on a Chiralcel
OD-RH column (15 cm) [mobile phase, H2O–MeCN
(75:25), 205 nm, 0.5 mL min–1, 25 °C; (–)-4b: tR = 13.29
min; (+)-4b: tR = 16.85 min].
Synlett 2008, No. 11, 1687–1689 © Thieme Stuttgart · New York